NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding NextCure, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 59 | 51 | −8 |
| Shares | 13.2M | 14.5M | +1.22M (+9.2%) |
| Value | $64.3M | $67.9M | +$3.62M (+5.6%) |
New holders (6)
Institutions that held NextCure, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| K2 Principal Fund, L.P. | 788,327 | $3.71M | 0.63% |
| FMR LLC | 336,900 | $1.58M | 0.00% |
| Assenagon Asset Management S.A. | 108,630 | $511.0K | 0.00% |
| XTX Topco Ltd | 21,929 | $103.0K | 0.04% |
| Two Sigma Investments, LP | 17,290 | $81.0K | 0.00% |
| Wells Fargo & Company | 119 | $1.00K | 0.00% |
Sold out (14)
Institutions that held NextCure, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Silverarc Capital Management, LLC | 196,187 | $953.0K |
| Woodline Partners LP | 161,638 | $786.0K |
| Susquehanna International Group, LLP | 111,012 | $540.0K |
| Atom Investors LP | 63,866 | $310.0K |
| Trexquant Investment LP | 36,981 | $180.0K |
| Veritable, L.P. | 36,807 | $179.0K |
| Bailard, Inc. | 30,600 | $149.0K |
| Squarepoint Ops LLC | 20,266 | $98.0K |
| Jane Street Group, LLC | 15,054 | $73.0K |
| Boothbay Fund Management, LLC | 13,470 | $65.0K |
| Corton Capital Inc. | 12,662 | $62.0K |
| Group One Trading, L.P. | 888 | $4.00K |
| High Net Worth Advisory Group LLC | 500 | $2.00K |
| Simplex Trading, LLC | 202 | $0 |